Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-11-25Clinical Trial Update: Clinical Study With Silymarin in the Patients With Chronic Hepatitis C Infection Who Failed Conventional Antiviral Therapy [Phase 3]
Phase 3 clinical trial evaluating silymarin in chronic hepatitis C patients who failed conventional antiviral therapy has completed.
-
CLINICAL_TRIALS trial_result · 2013-11-20Clinical Trial Update: Efficacy of Pegetron® Redipen™ Treatment and Treatment Compliance of Patients With Chronic Hepatitis C in Canada (P04423)
Clinical trial P04423 evaluated the efficacy and treatment compliance of Pegetron Redipen in chronic hepatitis C patients in Canada, with re…
-
CLINICAL_TRIALS trial_result · 2013-11-19Clinical Trial Update: Boceprevir Treatment in Participants With Chronic Hepatitis C Genotype 1 Deemed Nonresponders to Peginterferon/Ribavirin (P05514) [Phase 3]
Phase 3 clinical trial update for boceprevir in chronic hepatitis C genotype 1 nonresponders to peginterferon/ribavirin (P05514) completed w…
-
CLINICAL_TRIALS trial_result · 2013-11-13Clinical Trial Update: High Dose Insulin Therapy to Improve Liver Function [NA]
This clinical trial update discusses a study on high-dose insulin therapy to improve liver function in patients with hepatitis C, with the t…
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Study of the Pharmacokinetics and Safety of Asunaprevir in Patients With Kidney Disease [Phase 1]
Phase 1 study evaluating the pharmacokinetics and safety of Asunaprevir in patients with kidney disease has completed. The trial was sponsor…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-11-11Clinical Trial Update: Impact of Hepatitis C Virus Variability on Steatosis
A clinical trial investigating how Hepatitis C virus variability affects liver steatosis has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-11-08Clinical Trial Update: Pegylated Interferon and Ribavirin to Treat Chronic Hepatitis C With and Without Kidney Disease [Phase 4]
Phase 4 clinical trial results for pegylated interferon plus ribavirin to treat chronic hepatitis C, including patients with and without kid…
-
CLINICAL_TRIALS trial_result · 2013-11-07Clinical Trial Update: A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1 [Phase 2]
A Phase 2 study evaluating albuferon in combination with ribavirin for interferon-naive adults with chronic hepatitis C genotype 1 has compl…
-
CLINICAL_TRIALS trial_result · 2013-11-06Clinical Trial Update: Effect of Boceprevir on HCV-specific T Cell Responses
This completed clinical trial evaluated the effect of Boceprevir on HCV-specific T cell responses in chronic hepatitis C.
-
CLINICAL_TRIALS trial_result · 2013-11-05Clinical Trial Update: Safety, Tolerability, and Antiviral Activity of 24 or 48 Weeks of GS-9190 in Combination With Peginterferon Alfa 2a and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection [Phase 2]
Phase 2 study evaluating safety, tolerability, and antiviral activity of GS-9190 in combination with peginterferon alfa-2a and ribavirin for…
-
CLINICAL_TRIALS trial_result · 2013-10-31Clinical Trial Update: Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis C [Phase 2]
Phase 2 clinical trial evaluating interferon-alpha lozenges for prevention of relapse in chronic hepatitis C; study completed with results p…
-
CLINICAL_TRIALS trial_result · 2013-10-23Clinical Trial Update: A Phase II, Double-blinded, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Vitalliver in Patients With Decompensated Cirrhosis [Phase 2]
A Phase II double-blind, randomized trial evaluating Vitalliver in patients with decompensated cirrhosis has completed, assessing efficacy a…
-
CLINICAL_TRIALS trial_result · 2013-10-17Clinical Trial Update: Treatment of Acute Hepatitis C Virus in HIV Co-Infection [Phase 4]
Phase 4 trial update on treating acute hepatitis C virus in individuals co-infected with HIV; results completed and posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-10-16Clinical Trial Update: A Study to Investigate the Potential Pharmacokinetic Interaction Between TMC435 and Methadone [Phase 1]
Phase 1 study evaluating potential pharmacokinetic interaction between TMC435 and methadone in Hepatitis C patients; the trial has been comp…
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: TMC435-TiDP16-C113: A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics of TMC435 [Phase 1]
Phase 1 study assessing the effect of hepatic impairment on the pharmacokinetics of TMC435 in hepatitis C; the trial has completed.
-
CLINICAL_TRIALS trial_result · 2013-10-14Clinical Trial Update: TMC435-TiDP16-C126 - Trial to Investigate the Effect of Severe Renal Impairment on the Pharmacokinetics and Safety of TMC435 [Phase 1]
Completed Phase 1 study assessing how severe renal impairment affects the pharmacokinetics and safety of TMC435 in Hepatitis C.
-
CLINICAL_TRIALS trial_result · 2013-10-10Clinical Trial Update: Safety and Efficacy of Telaprevir in Combination With Peginterferon Alfa-2a and Ribavirin in Subjects Co-Infected With Hepatitis C Virus (HCV) and HIV [Phase 2]
This Phase 2 study evaluated the safety and efficacy of adding telaprevir to peginterferon alfa-2a and ribavirin in people co-infected with …
-
CLINICAL_TRIALS trial_result · 2013-10-08Clinical Trial Update: Silybin Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin Reduces Depression and Increases Work Ability [Phase 3]
Phase 3 trial evaluating silybin supplementation during hepatitis C therapy with pegylated interferon-α2b plus ribavirin found reduced depre…
-
CLINICAL_TRIALS trial_result · 2013-10-07Clinical Trial Update: Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy [Phase 4]
Phase 4 clinical trial update examining the prevalence, severity, and outcomes of antiviral therapy for Hepatitis C in patients receiving ma…
-
CLINICAL_TRIALS trial_result · 2013-09-24Clinical Trial Update: A Pilot Study of Boceprevir for the Treatment of Genotype 6 HCV [Phase 2]
This document provides an update on a Phase 2 pilot study evaluating boceprevir for genotype 6 hepatitis C infection.
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Study Comparing the Tolerability and Viral Reduction of the Combination of IFN a-2b XL + Ribavirin Versus Peg IFN a-2b + Ribavirin in Patients With Chronic Hepatitis C, Genotype 1 or 4 [Phase 2]
A Phase 2 study comparing tolerability and viral reduction between IFN alfa-2b XL + Ribavirin and Pegylated interferon alfa-2b + Ribavirin i…
-
CLINICAL_TRIALS trial_result · 2013-09-13Clinical Trial Update: A Study of PEGASYS (Pegylated-interferon Alfa-2a) With or Without Ribavirin in Patients With Chronic Hepatitis C Who Have Participated in Previous Roche or Roche Partner Protocols [Phase 3]
Phase 3 study of Pegasys (pegylated interferon alfa-2a) with or without ribavirin in chronic hepatitis C patients who previously participate…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Silybin - Vitamin E- Phospholipids Complex Reduces Liver Fibrosis in Patients With Chronic Hepatitis C Treated With Peg-IFN-a and RBV [Phase 3]
Phase 3 trial suggests that the silybin-Vitamin E-Phospholipids complex reduces liver fibrosis in patients with chronic hepatitis C treated …
-
CLINICAL_TRIALS trial_result · 2013-09-04Clinical Trial Update: A Study of Pegasys (Peginterferon Alfa-2a) Administered Alone or in Combination With Copegus (Ribavirin) in Patients With Chronic Hepatitis C Who Have Participated in Previous Pegasys Trials [Phase 3]
A Phase 3 clinical trial evaluating Pegasys (peginterferon alfa-2a) alone or with Copegus (ribavirin) in patients with chronic hepatitis C w…
-
CLINICAL_TRIALS trial_result · 2013-08-30Clinical Trial Update: A Phase 2b, Safety and Efficacy Study of Boceprevir in Patients Coinfected With HIV and Hepatitis C (P05411 AM4) [Phase 2]
Phase 2b study results for boceprevir in patients coinfected with HIV and hepatitis C, reporting safety and efficacy data.